SIMRIS B Stock Overview
Develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Simris Group AB (PUBL) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.13 |
| 52 Week High | SEK 0.35 |
| 52 Week Low | SEK 0.096 |
| Beta | 0.75 |
| 11 Month Change | -12.67% |
| 3 Month Change | 9.17% |
| 1 Year Change | -51.30% |
| 33 Year Change | -84.94% |
| 5 Year Change | -98.15% |
| Change since IPO | -99.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| SIMRIS B | SE Personal Products | SE Market | |
|---|---|---|---|
| 7D | 5.6% | -3.4% | -4.3% |
| 1Y | -51.3% | 6.0% | 12.6% |
Return vs Industry: SIMRIS B underperformed the Swedish Personal Products industry which returned 6% over the past year.
Return vs Market: SIMRIS B underperformed the Swedish Market which returned 12.6% over the past year.
Price Volatility
| SIMRIS B volatility | |
|---|---|
| SIMRIS B Average Weekly Movement | 18.1% |
| Personal Products Industry Average Movement | 4.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: SIMRIS B's share price has been volatile over the past 3 months.
Volatility Over Time: SIMRIS B's weekly volatility has increased from 13% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 9 | Alexis McIntosh | simrisalg.se |
Simris Group AB (PUBL) develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally. It offers skincare products and pharmaceuticals; food ingredients; and Algae Omega-3, an omega-3 EPA and DHA line under the SIMRIS brand name. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
Simris Group AB (PUBL) Fundamentals Summary
| SIMRIS B fundamental statistics | |
|---|---|
| Market cap | SEK 45.60m |
| Earnings (TTM) | -SEK 36.81m |
| Revenue (TTM) | SEK 4.39m |
10.4x
P/S Ratio-1.2x
P/E RatioIs SIMRIS B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIMRIS B income statement (TTM) | |
|---|---|
| Revenue | SEK 4.39m |
| Cost of Revenue | SEK 2.20m |
| Gross Profit | SEK 2.19m |
| Other Expenses | SEK 39.00m |
| Earnings | -SEK 36.81m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 49.92% |
| Net Profit Margin | -839.48% |
| Debt/Equity Ratio | 0% |
How did SIMRIS B perform over the long term?
See historical performance and comparison